Table 2

DLE lesion distribution based on CLASI scores in 112 Black and 71 non-Black patients

Anatomical locationBlack patients
n (%)
Non-Black patients
n (%)
Univariate
OR (95% CI)
P value*Multivariable
OR (95% CI)†‡
P value†‡
Scalp97 (87)51 (72)2.54 (1.12 to 5.79)0.0132.54 (1.20 to 5.37)0.015
Ears66 (59)32 (45)0.92 (0.92 to 3.33)0.0671.97 (1.06 to 3.68)§0.032
Nose/malar area60 (59)40 (56)0.89 (0.47 to 1.70)0.714
Rest of face63 (56)37 (53)1.18 (0.62 to 2.24)0.584
V area of neck (front)22 (20)19 (27)0.67 (0.31 to 1.44)0.260
Posterior neck/shoulders22 (20)20 (28)0.62 (0.29 to 1.33)0.181
Chest20 (18)18 (25)0.64 (0.29 to 1.41)0.223
Abdomen10 (9)1 (1)N/A¶0.053**
Back and buttocks27 (24)18 (25)0.94 (0.44 to 1.99)0.849
Arms40 (36)25 (35)1.02 (0.53 to 2.00)0.945
Hands19 (17)9 (13)1.41 (0.56 to 3.77)0.432
Legs23 (21)18 (25)0.76 (0.36 to 1.65)0.446
Feet20 (18)8 (11)1.71 (0.67 to 4.77)0.228
Mucous membrane15 (13)9 (13)1.07 (0.41 to 2.94)0.889
  • *P value was calculated with χ2 test unless otherwise specified.

  • †'–’ indicates that race was not a significant factor in multivariable analyses.

  • ‡Predictor variables (race, age at initial visit, gender, disease duration at initial visit, follow-up duration, smoking status, presence of SLE) were included in multivariable analyses.

  • §Race was the only significant predictor variable for scalp involvement. Race and age at initial visit (OR=0.97, 95% CI 0.95 to 0.99, p=0.015) were significant predictor variables for ear involvement.

  • ¶OR not calculated due to a low number of patients with abdomen involvement in the non-black patient group.

  • **P value was calculated with Fisher’s exact test.

  • CI, confidence interval; CLASI, Cutaneous Lupus Erythematosus Disease Area and Severity Index; DLE, discoid lupus erythematous; N/A, not available; OR, odds ratio.